Tag: Diabetes: Type II
ADA, EASD Issue New Recommendations for T2DM
Additional focus on lifestyle management, self-management education and support emphasized
Lixisenatide Cuts Kidney Damage in T2DM and Coronary Syndrome
Lixisenatide reduces progression of urinary albumin-creatinine ratio in patients with macroalbuminuria
Albiglutide Beats Placebo for Cardiovascular Events in T2DM
Despite having been withdrawn, albiglutide is superior to placebo for reducing cardiovascular events
Genetics May Identify Type 2 Diabetes Subtypes
Five clusters of T2DM loci and traits, each with distinct tissue-specific enhancer enrichment, identified
HbA1c Variability Is a Strong Predictor of Mortality in T2DM
HbA1c variability is a powerful, independent measure, regardless of how it is measured
Higher Aldosterone Levels Tied to Incident Type 2 Diabetes Risk
Racial/ethnic differences seen in the association of aldosterone with incident type 2 diabetes
FDA: Common Diabetes Meds Tied to Serious Genital Infection
Sodium-glucose cotransporter-2 inhibitors linked to 12 cases of Fournier's gangrene
Risk of Death Not Up in T2DM When Risk Factors Within Target
Little or no excess risk of death, MI, stroke for those with five risk-factor variables within target ranges
Two Strategies for Preventing Diabetes in Minority Patients
Physicians can stress the factors in a patient's control and change messaging about the condition
Weight Gain After Quitting Smoking May Up T2DM Risk
But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality
